Vesugen 20 mg

Technical Details

Dosage & Usage Guidelines

Vesugen is typically dosed at 10–20 mg per week in preclinical trials. Administration is usually subcutaneous, split into multiple injections across a 2–4 week research protocol. This peptide is non-hormonal, does not affect androgen or estrogen pathways, and supports tissue-specific action without systemic overload.

Peptide Stack Recommendations

Researchers aiming to expand on vascular or anti-aging outcomes frequently stack Vesugen with:

• GHK-Cu – promotes angiogenesis, wound repair, and vascular elasticity
• BPC-157 – regenerative peptide that supports endothelial and arterial wall healing
• SS-31 – mitochondrial peptide for oxidative stress reduction in blood vessels
• Thymalin – supports immune-endocrine interaction and system-wide peptide regulation
• AOD 9604 – for metabolic and anti-aging synergy

Safety Profile

Vesugen has shown no toxicity in research studies and does not negatively impact hormonal, hepatic, or renal systems. It is not associated with blood pressure spikes or cardiac strain. The peptide acts locally at the vascular tissue level and is rapidly metabolized. This product is strictly for laboratory research use and is not approved for human or veterinary use.

USA Shipping & Quality Compliance

Peptide Hubs offers fast, secure USA domestic shipping on Vesugen 20 mg and all other research peptides. All products are manufactured in GMP-certified laboratories and tested for identity, purity, and sterility. Vesugen is an excellent candidate for vascular rejuvenation and anti-aging peptide research.

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions